Unimed Access specializes in the design, development, and manufacturing of rare medical devices that address unmet clinical needs. Our team of biomedical engineers and regulatory experts work closely with healthcare providers to bring transformative solutions to market.
Our devices meet stringent regulatory requirements with full quality management system implementation.
From concept to clinical validation, we accelerate your medical device development timeline.
To develop clinically transformative medical technologies for patients with rare and orphan diseases through relentless innovation, scientific rigor, and compassionate patient-centered design.
A world where no patient suffers from lack of medical technology solutions due to disease rarity, economic constraints, or technical complexity.
Established with a mission to develop affordable, life-saving medical devices for underserved populations globally.
Founding principles: Access, Affordability, Innovation.
Successfully designed and tested a low-cost, rugged medical device (e.g., neonatal incubator, portable ventilator, wound care system) tailored for use in low-resource settings.
Field trials began in partnership with NGOs in Sub-Saharan Africa
First orphan device to receive FDA Breakthrough designation for rare genetic disorder treatment.
Reached over 5,000 patients in first year of global operations
Flagship device added to the World Health Organization’s list of essential innovations
Achieved CE mark and began steps for FDA 510(k) clearance
Partnered with UNICEF and GAVI to integrate devices into maternal and child health initiatives.
Collaborated with local governments for training programs in over 10 countries
Devices rapidly deployed during the Ebola outbreak in West Africa.
Enabled frontline workers to deliver care safely in austere environments
Launched regional production hubs in Kenya and India to reduce costs and support economic development
Created over 100 local jobs and shortened supply chain by 50%
Adapted technology for pandemic response (e.g., oxygen delivery, portable diagnostics).
Devices used in 30+ countries during critical COVID-19 surges.
Received international recognition for Best Medical Technology for Low-Resource Settings
Highlighted in The Lancet and Nature Medicine for impact
Celebrating 20 years of innovation in humanitarian health.
Cumulative impact:
1 million+ lives touched
50+ countries reached
100+ partnerships across NGOs, governments, and health systems.
Every design decision begins with patient needs and clinical outcomes
Pursuing technically complex solutions others deem impossible
Rigorous evidence-based development and transparent reporting
Partnering with clinicians, researchers, and patients at every stage
Exceeding quality standards for patient safety and device efficacy
Designing solutions accessible across healthcare systems worldwide
I’m Steffan Rhys, founder and principal consultant specializing in rare medical devices developed for low-prevalence conditions and humanitarian use. With over 20 years of experience in the medical device industry, I’ve dedicated my career to helping innovators bring critical technologies to underserved patient populations even when traditional commercial pathways fall short.
Devices designed for rare or orphan conditions face unique challenges: limited patient populations, complex regulatory requirements, and resource constraints. Yet these devices often have life-saving potential. My work is focused on helping organizations:
I support:
To ensure that every patient, no matter how rare their condition, has access to the technology they need. I believe the most meaningful innovation often happens in the margins, and I’m here to help bring it to light.
Whether you’re building a device for a rare disease, pursuing a humanitarian exemption, or navigating early-stage regulatory hurdles, I’d be honored to support your mission.
Our quality management system forms the foundation of every device we develop. We maintain:
Our regulatory team has successfully navigated 27 PMA supplements, 15 De Novo requests, and 42 510(k) clearances for orphan devices.